Enhancing evidence-based decision making through primary care provider–pharmacist collaboration and patient simulation training

Adam Chesler, Jessica Puckett-Beasley, Amir Shakouri, Michelle Borowski, David Eustis, David Paculdo, Isabella Cooney, John Paulo Vergara, Clive Fields, Trever Burgon
{"title":"Enhancing evidence-based decision making through primary care provider–pharmacist collaboration and patient simulation training","authors":"Adam Chesler,&nbsp;Jessica Puckett-Beasley,&nbsp;Amir Shakouri,&nbsp;Michelle Borowski,&nbsp;David Eustis,&nbsp;David Paculdo,&nbsp;Isabella Cooney,&nbsp;John Paulo Vergara,&nbsp;Clive Fields,&nbsp;Trever Burgon","doi":"10.1016/j.japhpi.2025.100031","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Traditionally, physicians’ and pharmacists’ roles have been distinct. However, an aging population, increasing prevalence of chronic conditions, the growth of value-based care payments, and forecasted shortfalls in primary care providers (PCPs) are forcing a rethinking of this paradigm. Creating opportunities for collaboration between PCPs and pharmacists presents an opportunity to address these challenges. This study explores the impact of this collaboration on evidence-based decision making at Village Medical and Walgreens.</div></div><div><h3>Methods</h3><div>Online simulated cases of patients with diabetes were randomly assigned to PCPs alone or PCP-pharmacist dyad pairs. The patient simulations were administered in 3 seasons in 2023, and participants completed the cases by making care decisions and receiving real-time feedback on improvement opportunities. Care decisions were scored against evidence-based guidelines. In the first season, PCPs completed cases alone to establish a practice baseline. For the next 2 seasons, 40 PCPs were each paired with a pharmacist and asked to complete their next 2 seasons of patient simulations together. Care decisions made by the dyad pairs were compared with 40 Village Medical matched PCPs completing the cases on their own.</div></div><div><h3>Results</h3><div>In the baseline season, we found no difference in the treatment domain between the predyad and control PCPs (64.0% vs. 63.2%, respectively). By the final season, treatment scores improved for both groups (up to 72.9% for the dyads and up to 68.9% for control), a difference-in-difference improvement of +3.2% for the dyads (<em>P</em> = 0.497). Stopping sulfonylureas and prescribing sodium-glucose cotransporter-2 inhibitors showed noteworthy difference-in-difference improvements among the dyads: +16.2% (<em>P</em> = 0.501) and +23.1% (<em>P</em> = 0.296), respectively.</div></div><div><h3>Conclusion</h3><div>This proof-of-concept study provides evidence that PCP-pharmacist collaboration can improve care decisions, especially in polypharmacy management, medication deprescribing, and evidence-based integration of new medications. The results support continued efforts to enhance collaboration between pharmacists and primary care to improve care quality.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 2","pages":"Article 100031"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAPhA Practice Innovations","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949969025000065","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Traditionally, physicians’ and pharmacists’ roles have been distinct. However, an aging population, increasing prevalence of chronic conditions, the growth of value-based care payments, and forecasted shortfalls in primary care providers (PCPs) are forcing a rethinking of this paradigm. Creating opportunities for collaboration between PCPs and pharmacists presents an opportunity to address these challenges. This study explores the impact of this collaboration on evidence-based decision making at Village Medical and Walgreens.

Methods

Online simulated cases of patients with diabetes were randomly assigned to PCPs alone or PCP-pharmacist dyad pairs. The patient simulations were administered in 3 seasons in 2023, and participants completed the cases by making care decisions and receiving real-time feedback on improvement opportunities. Care decisions were scored against evidence-based guidelines. In the first season, PCPs completed cases alone to establish a practice baseline. For the next 2 seasons, 40 PCPs were each paired with a pharmacist and asked to complete their next 2 seasons of patient simulations together. Care decisions made by the dyad pairs were compared with 40 Village Medical matched PCPs completing the cases on their own.

Results

In the baseline season, we found no difference in the treatment domain between the predyad and control PCPs (64.0% vs. 63.2%, respectively). By the final season, treatment scores improved for both groups (up to 72.9% for the dyads and up to 68.9% for control), a difference-in-difference improvement of +3.2% for the dyads (P = 0.497). Stopping sulfonylureas and prescribing sodium-glucose cotransporter-2 inhibitors showed noteworthy difference-in-difference improvements among the dyads: +16.2% (P = 0.501) and +23.1% (P = 0.296), respectively.

Conclusion

This proof-of-concept study provides evidence that PCP-pharmacist collaboration can improve care decisions, especially in polypharmacy management, medication deprescribing, and evidence-based integration of new medications. The results support continued efforts to enhance collaboration between pharmacists and primary care to improve care quality.
通过初级保健提供者-药剂师合作和患者模拟培训加强循证决策
传统上,医生和药剂师的角色是截然不同的。然而,人口老龄化、慢性病患病率上升、基于价值的护理支付的增长以及初级保健提供者(pcp)的预测短缺正在迫使人们重新思考这一范式。为pcp和药剂师之间的合作创造机会,为解决这些挑战提供了机会。本研究探讨了这种合作对乡村医疗和沃尔格林循证决策的影响。方法将在线模拟的糖尿病患者随机分为pcp组和pcp -药师组。患者模拟于2023年分3个季节进行,参与者通过做出护理决策并获得改进机会的实时反馈来完成病例。根据循证指南对护理决策进行评分。在第一季,pcp单独完成病例以建立实践基线。在接下来的两个季节里,40名pcp分别与一名药剂师配对,并被要求一起完成他们接下来的两个季节的患者模拟。将两两配对的护理决定与40名村医疗匹配的pcp自己完成病例进行比较。结果在基线季节,我们发现在治疗域上,预防组和对照组的pcp无差异(分别为64.0%和63.2%)。到最后一季,两组的治疗得分都有所提高(二组最高为72.9%,对照组最高为68.9%),二组的差异改善为+3.2% (P = 0.497)。停用磺脲类药物和处方钠-葡萄糖共转运蛋白-2抑制剂在两组患者中表现出显著的差异改善:分别为+16.2% (P = 0.501)和+23.1% (P = 0.296)。结论这一概念验证研究提供了证据,证明药师合作可以改善护理决策,特别是在多药房管理、药物处方和新药物的循证整合方面。结果支持继续努力加强药剂师和初级保健之间的合作,以提高护理质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信